findmyKOL
Clinical trialNCT00859781Active, not recruitingPhase 2Interventional

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

SponsorWeill Medical College of Cornell UniversityEnrollment55Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cedars Sinai

    Los Angeles, California, United States

  • Usc/norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • Georgetown University Medical Center

    Washington D.C., District of Columbia, United States

  • Indiana University Melvin and Bren Simon Cancer Center

    Indianapolis, Indiana, United States

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

  • the University of Kansas Cancer Center

    Westwood, Kansas, United States

  • Weill Cornell Medical College

    New York, New York, United States

  • Upmc Hillman Cancer Center

    Pittsburgh, Pennsylvania, United States

  • University of Utah

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2009
Primary completion
10 Feb 2022
Completion
30 Sept 2026
Last update posted
8 Apr 2026
Registered enrollment
55
Registry id
NCT00859781

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.